SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MRK: Merck & Co., Inc.
MRK 85.98-0.3%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: telephonics2/20/2005 9:09:29 AM
   of 22
 
Our media loves to build up horror stories. Good news doesn't sell newspapers nor attract viewers to TV news programs. A point to consider is the current uproar about the use of Cox-2 inhibitors-Vioxx,Bextra abd Celebrex. According to the "stories", the use of these kills patients. But I'd like to suggest a different clinical trial. One set of patients would be those with unbearable intractable long term pain and the study would be designed to discern how many heart problems would arise in this population were they denied these drugs. I'd hazzard a guess that the numbers of "incidents" would be far higher than those getting pain relief from these medications.
My wife has been prescribed each in turn to see which helped her the most.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext